Loading...

Roivant Sciences Ltd.

ROIV•NASDAQ
Healthcare
Biotechnology
$11.55
$0.17(1.49%)

Roivant Sciences Ltd. (ROIV) Company Profile & Overview

Explore Roivant Sciences Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Roivant Sciences Ltd. (ROIV) Company Profile & Overview

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

SectorHealthcare
IndustryBiotechnology
CEOMatthew Gline

Contact Information

https://roivant.com
44 2074 003 347
11-12 St. James's Square, London, SW1Y 4LB

Company Facts

908 Employees
IPO DateDec 8, 2020
CountryGB
Actively Trading

Frequently Asked Questions

;